Rapidly Progressive Multicentric Castleman’s Disease in Patient with Acute Retroviral Syndrome: A Case Report by Hassan A et al.
Hassan A, Carroll C, Espina T (2015) Rapidly Progressive Multicentric Castleman’s Disease in Patient with Acute Retroviral Syndrome: A Case Report. Int J AIDS Res. 02(4), 34-36
34
http://scidoc.org/IJHR.php
Rapidly Progressive Multicentric Castleman’s Disease in Patient with Acute Retroviral Syndrome:        
A Case Report
           Case Report
Hassan A*, Carroll C, Espina T
Advocate Illinois Masonic Medical center, Chicago, USA.
*Corresponding Author: 
Abdalla Hassan, MD,
Internal Medicine Resident, Internal Medicine Department, 7th floor
Advocate Illinois Masonic Medical Center, 836 W Wellington Ave, 
Chicago, IL 60657, USA.
Tel: +1-347-873-2073
E-mail: abdalla.hassan@advocatehealth.com
Recieved: April 06, 2015
Accepted: April 29, 2015
Published: May 05, 2015
Citation: Hassan A, Carroll C, Espina T (2015) Rapidly Progressive 
Multicentric Castleman’s Disease in Patient with Acute Retroviral Syn-
drome: A Case Report. Int J AIDS Res. 02(4), 34-36. doi: http://dx.doi.
org/10.19070/2379-1586-150007
Copyright: Hassan A© 2015. This is an open-access article distributed 
under the terms of  the Creative Commons Attribution License, which 
permits unrestricted use, distribution and reproduction in any medium, 
provided the original author and source are credited.
Introduction 
Multicenteric Castleman’s Disease (MCD) or angiofollicular dys-
plasia is a lymphoproliferative disorder that happens with in-
creased frequency in Human Herpes Virus-8 (HHV-8) positive 
HIV patients. HHV-8 also causes Kaposi sarcoma and primary 
effusion lymphoma, and it is responsible for around 50% of  
MCD cases. We present a very unique case of  rapidly progressive 
Multicenteric Castleman’s Disease in newly diagnosed HIV posi-
tive male with acute retroviral syndrome before the initiation of  
Anti- Retroviral Therapy (ART).
Case Presentation
A 40 year old homosexual male presented to our institution with 
fevers, chills and a syncopal episode. He has a past medical history 
of  hypertension and illicit drug use. He was originally seen at an 
outside clinic for anal pain and was diagnosed with HIV five days 
prior to his admission. Two weeks prior to his admission he had 
also experienced an episode of  syncope, followed by 5 days of  
fever and chills and diffuse body aches. He also reported having a 
negative HIV test 2 months earlier. On presentation to emergency 
department he was not in acute distress, febrile with a tempera-
ture of  101ºF (38.3 ºC), tachycardic (max HR= 110) and normo-
tensive. Physical examination demonstrated right sided non ten-
der cervical lymphadenopathy with hepatosplenomegaly. His labs 
were significant for pancytopenia (WBC of  4.1 thousand/mcL; 
HgB 6.1gm/dL; MCV82fL; Platelet 78 thousand/mcL), hypona-
tremia (131mmol/L), and elevated creatinine (1.5mg/dL). Chest 
X-Ray was not impressive.
At that time the working diagnosis was acute retroviral syndrome 
given his symptoms and lab findings, although the anemia was too 
severe to be due to HIV only. Immediately he was transfused 2 
units of  Packed Red Blood Cells. His repeat Hemoglobin showed 
minimal improvement despite transfusion and this was very unu-
sual in case of  acute retroviral syndrome. Haptogoblin and bili-
rubin were normal. Peripheral blood smear showed spherocytosis 
and iron studies were significant for anemia of  chronic disease.
Later that day Computed Tomography of  Abdomen and Pelvis 
was done and it was significant for hepatosplenomegaly with mul-
tiple enlarged retroperitoneal lymph nodes in the abdomen and 
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pelvis (Figure 1). Based on these findings and the overall clinical 
picture, lymph node biopsy was obtained and it was consistent 
with HHV-8 associated Multicentric Castleman’s disease (MCD) 
(Figure 2). At that stage he was started on Anti-Retroviral Thera-
py for HIV with Gancyclovir and Rituxamab for MCD.
Two days later, he continued to deteriorate and his hemoglobin 
continued to drop requiring multiple units of  blood transfusion. 
His platelets continued to drop, and three days after that devel-
oped severe respiratory distress resulting in transfer to Medical 
Intensive Care Unit (MICU). On the second day in the MICU, 
patient platelet count dropped to less than 10 and transfused mul-
tiple units of  platelets. Next day he was ventilated due to severe 
Acute Respiratory Distress Syndrome, and one day after that he 
expired.
Discussion
Castleman's disease is a benign disorder first described by Dr. 
Benjamin Castleman in 1956. Castleman's disease is also referred 
to as angiofollicular hyperplasia, and is non-clonal disease of  the 
lymphnodes. The usual presentation is with lymphadenopathy 
and systemic symptoms including fever, night sweats, and weight 
loss. The disease commonly involves spleen, liver, lymph nodes 
(abdominal and peripheral) [1]. In individuals infected with HIV, 
Multicentric Castleman’s Disease (MCD) is almost exclusively 
caused by infection with a HHV-8 {which is also known as Ka-
posi sarcoma-associated herpesvirus (KSHV)}. This may be con-
sidered a separate entity from the non-HHV8 related or idiopath-
ic form of  multicentric Castleman’s disease and from unicentric 
forms of  Castleman’s disease.
Figure 1. CT abdomen/pelvis with contrast reveals hepatosplenomegaly with lymphadenopathy (enlarged retroperitoneal 
lymph nodes).
Figure 2. Right Inguinal Lymph Node biopsy. (A-C) Microscopic views consistent with MulticentricCastleman’s Disease 
(MCD), it reveals angiofollicular hyperplasia with plasmablastic proliferation (H&E). (D) Immunohistochemical staining 
positive for HHV-8.
Several case reports have associated the development of  MCD 
with the initiation of  Anti-Retroviral Therapy (ART) [2]. The 
exact pathophysiology of  MCD is still controversial, with IL-6 
playing a major role in immune disruption and hypergammaglob-
ulinemia [3]. It is postulated that it arises from immune dysregula-
tion secondary to immune reconstitution syndrome and intrinsic 
properties of  HHV-8 which allows for virally-encoded secretion 
of  IL-6 [4]. Thus, though rare, the historical incidence has since 
been noted to be on the rise as more patients are started on ART 
[5].
The case that has been presented above is a deviation from usual 
natural history of  the development of  MCD. An observational 
study done by Katchanov et al. has described that the temporal 
relationship has been described to occur within the 12 months 
of  ART initiation [6]. Our patient presented was noted to have 
inguinal lymphadenopathy with hepatosplenomegaly on admis-
sion before the initiation of  antiretroviral therapy. He was not 
started on HAART before the lymph node biopsy was done. He 
was subsequently started on HAART, but continued to have more 
progressive symptoms and eventually succumbed to his disease. 
Rapidly progressive MCD has been historically associated to the 
initiation of  antiretroviral therapy. Our case suggests that other 
pathological pathways exist in the development of  MCD. There 
are no case reports to date that demonstrated such a presentation 
of  rapidly progressive Multicentric Castleman’s Disease in acute 
retroviral syndrome.
Conclusion
In conclusion, we believe that the occurrence of  Castleman’s dis-
ease in patients with acute HIV before the initiation of  ART is a 
very poor prognostic sign and physicians should be aware about 
such entity.
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